🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 31 (from laksa184)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa031.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, meta_canonical AS meta_canonical, ml_categories_json AS ml_categories_json, ml_types_json AS ml_types_json, ml_intent_types_json AS ml_intent_types_json, meta_language AS meta_language, attrs_author AS attrs_author, ifNull(toUnixTimestamp(attrs_publish_time), 0) AS attrs_publish_time, ifNull(toUnixTimestamp(attrs_original_publish_time), 0) AS attrs_original_publish_time, ifNull(attrs_is_republished, 0) AS attrs_is_republished, ifNull(attrs_nr_words, 0) AS attrs_nr_words, ifNull(attrs_boilerpipe_nr_words, 0) AS attrs_boilerpipe_nr_words, ifNull(body_ext_links_number, 0) AS body_ext_links_number, ifNull(body_int_links_number, 0) AS body_int_links_number, ifNull(meta_nofollow, 0) AS meta_nofollow, ifNull(meta_noarchive, 0) AS meta_noarchive, ifNull(props_was_rendered, 0) AS props_was_rendered, ifNull(src_redirect, \'\') AS src_redirect, ifNull(download_time_msec, 0) AS download_time_msec, ifNull(download_ttfb_msec, 0) AS download_ttfb_msec, ifNull(download_size, 0) AS download_size FROM crawler3.page_info_local FINAL PREWHERE int_partition_id = 55 AND (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.mdpi.com/1999-4915/16/11/1795\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.mdpi.com/1999-4915/16/11/1795\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.mdpi.com\/1999-4915\/16\/11\/1795","crawl_time":1776900190,"first_indexed_time":1732068067,"http_code":200,"src_unparsed":"com,mdpi!www,\/1999-4915\/16\/11\/1795 s443","src_root_hash":"11974975279136771031","history_drop_reason":null,"meta_title":"Beyond Antivirals: Alternative Therapies for Long COVID","meta_descriptions":["Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) is a condition characterized by numerous lingering symptoms that persist for weeks to months following the viral illness. While treatment for PASC is still evolving, several therapeutic approaches beyond traditional antiviral therapies are being investigated, such as immune-modulating agents, anti-inflammatory drugs, and various supportive interventions focusing at alleviating symptoms and enhancing recovery. We aimed to summarize the breadth of available evidence, identify knowledge gaps, and highlight promising non-antiviral therapies for Long COVID\/PASC. We followed the framework of a scoping methodology by mapping existing evidence from a range of studies, including randomized clinical trials, observational research, and case series. Treatments evaluated include metformin, low-dose naltrexone (LDN), dexamethasone, statins, omega-3 fatty acids, L-arginine, and emerging therapies like intravenous immunoglobulin (IVIg) and therapeutic apheresis. Early findings suggest that metformin has the strongest clinical evidence, particularly from large phase 3 trials, while LDN and dexamethasone show potential based on observational studies. However, many treatments lack robust, large-scale trials. This review emphasizes the need for further research to confirm the efficacy of these treatments and guide clinical practice for Long COVID management."],"meta_canonical":null,"ml_categories_json":"{\"\/Health\":970,\"\/Health\/Alternative_and_Natural_Medicine\":632,\"\/Health\/Alternative_and_Natural_Medicine\/Other\":486,\"\/Science\":113,\"\/Science\/Biological_Sciences\":112,\"\/Science\/Biological_Sciences\/Other\":102}","ml_types_json":"{\"\/Article\":997,\"\/Article\/Study_or_Research_Findings\":966}","ml_intent_types_json":"{\"Informational\":999}","meta_language":"en","attrs_author":null,"attrs_publish_time":0,"attrs_original_publish_time":1732068067,"attrs_is_republished":0,"attrs_nr_words":"15767","attrs_boilerpipe_nr_words":"11534","body_ext_links_number":417,"body_int_links_number":91,"meta_nofollow":0,"meta_noarchive":0,"props_was_rendered":1,"src_redirect":"","download_time_msec":758,"download_ttfb_msec":710,"download_size":95195}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📍

LOCATION

Host 31 · Partition 55

laksa031

11974975279136771031

📄

INDEXABLE

✅

CRAWLED

1 month ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	1.4 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property

Value

URL

https://www.mdpi.com/1999-4915/16/11/1795

Last Crawled

2026-04-22 23:23:10 (1 month ago)

First Indexed

2024-11-20 02:01:07 (1 year ago)

HTTP Status Code

200

Content

Meta Title

Beyond Antivirals: Alternative Therapies for Long COVID

Meta Description

Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) is a condition characterized by numerous lingering symptoms that persist for weeks to months following the viral illness. While treatment for PASC is still evolving, several therapeutic approaches beyond traditional antiviral therapies are being investigated, such as immune-modulating agents, anti-inflammatory drugs, and various supportive interventions focusing at alleviating symptoms and enhancing recovery. We aimed to summarize the breadth of available evidence, identify knowledge gaps, and highlight promising non-antiviral therapies for Long COVID/PASC. We followed the framework of a scoping methodology by mapping existing evidence from a range of studies, including randomized clinical trials, observational research, and case series. Treatments evaluated include metformin, low-dose naltrexone (LDN), dexamethasone, statins, omega-3 fatty acids, L-arginine, and emerging therapies like intravenous immunoglobulin (IVIg) and therapeutic apheresis. Early findings suggest that metformin has the strongest clinical evidence, particularly from large phase 3 trials, while LDN and dexamethasone show potential based on observational studies. However, many treatments lack robust, large-scale trials. This review emphasizes the need for further research to confirm the efficacy of these treatments and guide clinical practice for Long COVID management.

Meta Canonical

null

Boilerpipe Text

heavy column, fetched on demand

Markdown

heavy column, fetched on demand

Readable Markdown

heavy column, fetched on demand

ML Classification

ML Categories

/Health		97.0%
/Health/Alternative_and_Natural_Medicine		63.2%
/Health/Alternative_and_Natural_Medicine/Other		48.6%
/Science		11.3%
/Science/Biological_Sciences		11.2%
/Science/Biological_Sciences/Other		10.2%

Raw JSON

{
    "/Health": 970,
    "/Health/Alternative_and_Natural_Medicine": 632,
    "/Health/Alternative_and_Natural_Medicine/Other": 486,
    "/Science": 113,
    "/Science/Biological_Sciences": 112,
    "/Science/Biological_Sciences/Other": 102
}

ML Page Types

/Article		99.7%
/Article/Study_or_Research_Findings		96.6%

Raw JSON

{
    "/Article": 997,
    "/Article/Study_or_Research_Findings": 966
}

ML Intent Types

Informational

99.9%

Raw JSON

{
    "Informational": 999
}

Content Metadata

Language

Author

null

Publish Time

not set

Original Publish Time

2024-11-20 02:01:07 (1 year ago)

Republished

Word Count (Total)

15,767

Word Count (Content)

11,534

Links

External Links

417

Internal Links

Technical SEO

Meta Nofollow

Meta Noarchive

JS Rendered

Yes

Redirect Target

null

Performance

Download Time (ms)

758

TTFB (ms)

710

Download Size (bytes)

95,195

Location

Host ID

31 (laksa031)

Partition ID

Root Hash

11974975279136771031

Unparsed URL

com,mdpi!www,/1999-4915/16/11/1795 s443